FI107707B - Puskurikäyttö tehoainetta sisältävässä transdermaalisessa järjestelmässä - Google Patents

Puskurikäyttö tehoainetta sisältävässä transdermaalisessa järjestelmässä Download PDF

Info

Publication number
FI107707B
FI107707B FI913645A FI913645A FI107707B FI 107707 B FI107707 B FI 107707B FI 913645 A FI913645 A FI 913645A FI 913645 A FI913645 A FI 913645A FI 107707 B FI107707 B FI 107707B
Authority
FI
Finland
Prior art keywords
skin
active ingredient
active
additive
patch
Prior art date
Application number
FI913645A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI913645A0 (fi
Inventor
Bernd Zierenberg
Arun Rajaram Gupte
Uwe Rohr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI913645A0 publication Critical patent/FI913645A0/fi
Application granted granted Critical
Publication of FI107707B publication Critical patent/FI107707B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
FI913645A 1989-12-01 1991-07-31 Puskurikäyttö tehoainetta sisältävässä transdermaalisessa järjestelmässä FI107707B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3939703 1989-12-01
DE3939703A DE3939703C2 (de) 1989-12-01 1989-12-01 Verbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
PCT/EP1990/002052 WO1991007998A1 (de) 1989-12-01 1990-11-29 VERBESSERTES TRANSDERMALES SYSTEM ZUR APPLIKATION VON PHARMAKOLOGISCH AKTIVEN VERBINDUNGEN UNTER pH-KONTROLLIERTEN BEDINGUNGEN
EP9002052 1990-11-29

Publications (2)

Publication Number Publication Date
FI913645A0 FI913645A0 (fi) 1991-07-31
FI107707B true FI107707B (fi) 2001-09-28

Family

ID=6394557

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913645A FI107707B (fi) 1989-12-01 1991-07-31 Puskurikäyttö tehoainetta sisältävässä transdermaalisessa järjestelmässä

Country Status (20)

Country Link
EP (1) EP0456792B1 (es)
JP (1) JPH04506811A (es)
KR (1) KR0143549B1 (es)
AT (1) ATE185492T1 (es)
AU (1) AU637861B2 (es)
CA (1) CA2046337C (es)
DE (2) DE3939703C2 (es)
DK (1) DK0456792T3 (es)
ES (1) ES2139570T3 (es)
FI (1) FI107707B (es)
GR (1) GR3032175T3 (es)
HU (1) HU206993B (es)
IE (1) IE904322A1 (es)
IL (1) IL96506A (es)
NO (1) NO302156B1 (es)
NZ (1) NZ236280A (es)
PT (1) PT96045B (es)
RU (1) RU1834665C (es)
WO (1) WO1991007998A1 (es)
ZA (1) ZA909624B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
ATE310539T1 (de) 2001-12-21 2005-12-15 Coloplast As Artikel zur wundbehandlung
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4830856A (en) * 1987-01-27 1989-05-16 Peppers James M Chelation product
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
AU4745390A (en) * 1988-12-01 1990-06-26 Schering Corporation Compositions for transdermal delivery of estradiol
DE3843557A1 (de) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermales therapeutisches system zur verabreichung von clenbuterol

Also Published As

Publication number Publication date
ZA909624B (en) 1992-08-26
EP0456792B1 (de) 1999-10-13
PT96045A (pt) 1991-09-13
KR0143549B1 (ko) 1998-07-01
DE3939703A1 (de) 1991-06-06
HU206993B (en) 1993-03-01
NO302156B1 (no) 1998-02-02
CA2046337C (en) 2004-05-25
ATE185492T1 (de) 1999-10-15
FI913645A0 (fi) 1991-07-31
IE904322A1 (en) 1991-06-05
DE3939703C2 (de) 1998-07-02
JPH04506811A (ja) 1992-11-26
IL96506A (en) 1996-01-19
PT96045B (pt) 1998-01-30
GR3032175T3 (en) 2000-04-27
EP0456792A1 (de) 1991-11-21
AU6875791A (en) 1991-06-26
RU1834665C (ru) 1993-08-15
CA2046337A1 (en) 1991-06-02
NZ236280A (en) 1994-06-27
HU912638D0 (en) 1992-01-28
DK0456792T3 (da) 2000-04-03
AU637861B2 (en) 1993-06-10
KR920700704A (ko) 1992-08-10
ES2139570T3 (es) 2000-02-16
IL96506A0 (en) 1991-08-16
HUT59615A (en) 1992-06-29
DE59010885D1 (de) 1999-11-18
WO1991007998A1 (de) 1991-06-13
NO912985D0 (no) 1991-07-31
NO912985L (no) 1991-07-31

Similar Documents

Publication Publication Date Title
US5462744A (en) Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
FI82602B (fi) Foerfarande foer framstaellning av verksamma plaoster.
CA1272954A (en) Ph-mediated drug delivery system
CA1336071C (en) Pharmaceutical composition for systemic transdermal administration
CA2033113C (en) Estrogen-containing gel preparation
AU2010319065B2 (en) Pharmaceutical composition for external use
JPH0220606B2 (es)
WO1987000042A1 (en) Transdermal verapamil delivery device
US5252588A (en) Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
US5399355A (en) Agent for transdermal administration containing ergoline derivatives
KR20050038007A (ko) 로티고틴 투여를 위한 고온-용융 티티에스
JP2005506297A (ja) ペルゴリドの経皮送達
JP2000044476A (ja) フェンタニル含有経皮吸収投与マトリックス型貼付剤
FI107707B (fi) Puskurikäyttö tehoainetta sisältävässä transdermaalisessa järjestelmässä
CA2041330C (en) Percutaneously absorbable eperisone or tolperisone preparation
US4826686A (en) Therapeutic system
MX2007011681A (es) Parche transdermico.
KR100549846B1 (ko) 활성물질 스코폴라민 염기를 함유하는 경피 치료 시스템
JPH0424324B2 (es)
CA2381468A1 (en) Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders
JP2021504319A (ja) 接着性可塑剤−ポリマーマトリックスに基づく経皮治療システム
Kharia et al. Overview of Transdermal Medicated Patches with its research updates in preceding years
JPH02149514A (ja) 医薬部材
JPH07145061A (ja) 経皮吸収製剤
KR100563194B1 (ko) 펜타닐을 유효성분으로 함유하는 경피투여제제